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Purpose: In vivo 1H and 31P magnetic resonance spectroscopic imaging (MRSI) provide comple-
mentary information on the biology of prostate cancer. In this work we demonstrate the feasibility of
performing multiparametric imaging (mpMRI) and 1H and 31P spectroscopic imaging of the prostate
using a 31P and 1H endorectal radiofrequency coil (ERC) in combination with a multitransmit body
array at 7 Tesla (T).
Methods: An ERC with a 31P transceiver loop coil and 1H receive (Rx) asymmetric microstrip (31P/1H
ERC) was designed, constructed and tested in combination with an external 8-channel 1H transceiver
body array coil (8CH). Electromagnetic field simulations and measurements and in vivo temperature
measurements of the ERC were performed for safety validation. In addition, the signal-to-noise (SNR)
benefit of the 1H microstrip with respect to the 8CH was evaluated. Finally, the feasibility of the setup
was tested in one volunteer and three patients with prostate cancer by performing T2-weighted and diffu-
sion-weighted imaging in combination with 1H and 31P spectroscopic imaging.
Results: Electromagnetic field simulations of the 31P loop coil showed no differences in the E- and B-
fields of the 31P/1H ERC compared with a previously safety validated ERC without 1H microstrip. The
hotspot of the specific absorption rate (SAR) at the feed point of the 31P/1H ERC loop coil was 9.42 W/
kg when transmitting on 31P at 1 W. Additional in vivo measurements showed a maximum temperature
increase at the SAR hotspot of 0.7°C over 6 min on 31P at 1.9 W transmit (Tx) power, indicating safe
maximum power levels. When transmitting with the external 1H body array at 40W for 2:30 min, the
temperature increase around the ERC was < 0.3°C. Up to 3.5 cm into the prostate the 1H microstrip of
the ERC provided higher SNR than the 8CH. The total coil combination allowed acquisition of an
mpMRI protocol and the assessment of 31P and 1H metabolites of the prostate in all test subjects.
Conclusion: We developed a setup with a 31P transceiver and 1H Rx endorectal coil in combination
with an 8-channel transceiver external body array coil and demonstrated its safety and feasibility for
obtaining multiparametric imaging and 1H and 31P MRSI at 7T in patients with prostate cancer
within one MR examination. © 2019 The Authors. Medical Physics published by Wiley Periodicals,
Inc. on behalf of American Association of Physicists in Medicine. [https://doi.org/10.1002/mp.13696]
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1. INTRODUCTION
Proton magnetic resonance spectroscopic imaging (MRSI) is
used to study the in vivo metabolic profile of the prostate by
detecting and localizing the levels of citrate, choline, creatine
and polyamines.1–4 An increase in the ratio of choline over
citrate, which is partly attributed to increased levels of cho-
line, has been described as a valuable biomarker to discrimi-
nate prostate cancer from healthy prostate tissue.5 It indicates
prostate cancer specific changes in the phospholipid metabo-
lism which plays an important role in cell membrane genera-
tion and degradation.5–8 This phospholipid metabolism can
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be studied in more detail when using 31P-MRSI to assess the
levels of the phosphomonoesters (PMEs): phosphocholine
(PC) and phosphoethanolamine (PE), and the phosphodi-
esters (PDEs): glycerophosphocholine (GPC) and glyc-
erophosphoethanolamine (GPE).9–11 Parts of the PME and
PDE signals, together with resonances of free choline, free
ethanolamine, taurine, and myo-inositol, comprise the total
choline (tCho) peak at 3.2 ppm in 1H spectroscopy.11 Since
31P and 1H spectroscopy of the prostate provide complemen-
tary information on tumor biology, it would be of high inter-
est to obtain both within one measurement session. Ideally,
this would even be combined with T2-weighted (T2W) and
diffusion-weighted imaging (DWI) of the prostate, as these
are paramount in accurate localization and characterization of
potential prostate cancer lesions.
The combination of 1H and 31P spectroscopy and 1H imag-
ing requires a radiofrequency (RF) coil setup with transmit
(Tx) and receive (Rx) capabilities on both nuclei,12 preferably
one in which no coils need to be exchanged during the exami-
nation.
Because of the lower intrinsic magnetic resonance (MR)
sensitivity of 31P compared to 1H and the low concentration of
31P metabolites in the human body, 31P spectroscopy of the
prostate is challenging. 31P MRSI should preferably be per-
formed at 7 Tesla with an endorectal radiofrequency coil
(ERC) to optimize signal-to-noise (SNR) and to increase spec-
tral resolution. However, for T2W imaging and DWI of the
prostate at 7T, only using an endorectal coil is inadequate.
Transmitting radiofrequency pulses with a small local surface
coil results in substantial transition bands in T2W and DWI
images due to its severely inhomogeneous transmit profile.12,13
This can be solved by using a multichannel external body array
in combination with B1
+ shimming to provide a homogeneous
transmit field.13,14 Since an endorectal coil is needed for 31P,
this ERC can also be equipped with 1H receive capabilities to
enhance 1H imaging and spectroscopy of the prostate, increas-
ing SNR for 1H spectroscopy and spatial resolution for T2W
imaging and DWI. Moreover, the 1H transmit capabilities of
the external body array allow the use of the nuclear Overhauser
effect for an extra increase in 31P SNR.15
Therefore, we introduce and evaluate a coil setup with a
31P Tx/Rx – 1H Rx ERC in combination with an 8-channel
external multitransmit 1H array to enable multiparametric
imaging and 1H and 31P spectroscopic imaging of the prostate
at 7T. We perform electromagnetic field simulations, phan-
tom measurements and in vivo temperature measurements to
validate the safety of the setup. In addition, we evaluate its
SNR performance and demonstrate the feasibility of the com-
plete setup in three patients and a volunteer.
2. METHODS
2.A. Subjects
One healthy volunteer (age 40 yr, weight 83 kg) and three
patients (age: 60, 63, and 67 yr, weight: 97, 83, and 88 kg)
with histopathologically proven prostate cancer were
measured using the setup described below. An intramuscular
injection of butylscopolamine bromide (Buscopan, Boehrin-
ger-Ingelheim, Ingelheim, Germany) was used to suppress
peristalsis. For all volunteer and patient measurements,
informed consent was signed and the study was approved by
the institutional review board.
2.B. Hardware
All MR measurements were performed on a 7-Tesla
whole-body MRI system (MAGNETOM, Siemens Health-
care, Erlangen, Germany). Specific absorption rate (SAR)
monitoring of the 1H and 31P measurements was performed
with a custom build SAR supervision system, which mea-
sured the time-averaged input power over 10 s and over
6 min. This input power was not to exceed the safety levels
based on local SAR restrictions, otherwise the safety system
would stop the measurement.
2.B.1. Combined 31P Tx/Rx and 1H Rx endorectal
coil ( 31P/ 1H ERC)
The mechanical housing and conductors of a 3T endorectal
1H receive (Rx) coil (MEDRAD, Pittsburgh, PA) were disas-
sembled and equipped with a 1H receive element and a 31P
transceiver loop coil. The 1H Rx element was placed directly
on the plastic rod16 and consisted of an asymmetric microstrip
of length 53 mm, with a distance of 4 mm between the con-
ducting line and the ground plane [Fig. 1(a)]. By rotating the
conducting line with respect to the axis of the plastic rod, the
B1
- profile was oriented in the same direction as the receive
profile of the 31P loop coil. The coil was tuned and matched to
297.2 MHz and a series PIN diode was used for detuning the
microstrip during transmit with the external 1H coil. The loop
coil was tuned and matched to 50 O at 120.3 MHz for 31P at
7T and was mounted on top of the inner balloon (Fig. 1).10 In
every patient measurement, after the final coil placement, the
tuning and matching was checked using a network analyzer, as
it slightly depends on the inflation of the inner balloon. The
inner balloon was inflated using inert perfluoro-polyether liq-
uid (Fomblin, Solvay Solexis, Bollate, Italy). To eliminate any
common modes a 1H cable trap was placed directly at the
cable exit of the plastic rod. Finally, a balun was added to the
1H Rx element at the final part of the 1H cabling in the plastic
rod (Fig. 2). The 31P transceiver loop was connected via a
coaxial cable to a Tx/Rx switch with integrated small-band
low-noise preamplifier (Ar2 Communication Products,
Burlington US). The received signals from the 1H microstrip
were routed through a separate coaxial cable to its own inter-
face with integrated 1H preamplifier (Ar2 Communication
Products, Burlington US). These electronics were used to
interface the elements in the ERC to the MR system.
2.B.2. 1H external array coil
The 1H external multitransmit RF body coil consisted of
two arrays containing four microstrip elements with
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meanders.10,17,18 The arrays were put ventrally and dorsally of
the body. The coil channels were powered by eight 1 kW
amplifiers (LPPA 13080W, Dressler, Germany) and were
connected using a separate Tx/Rx switch. The cable length
between elements and switch box was adjusted to achieve
preamplifier decoupling during reception.
2.B.3. In vivo 1H performance of 31P/ 1H endorectal
coil
To evaluate the in vivo performance of the asymmetric
microstrip 1H receive element, we performed in vivo SNR
measurements within the prostate to compare the SNR of the
ERC with the SNR of the 8-channel external body array
(8CH). Gradient echo (GRE) imaging in transversal and
sagittal orientation (TR = 25 ms, TE = 4.1 ms, field of view
(FOV) = 261 9 380 mm2, matrix = 176 9 256, 3 slices,
one average, bandwidth 241 Hz/pixel) of the healthy volun-
teer was performed with the ERC in situ, using the external
body array for transmit and either only the 8-channel external
body array or only the ERC for receive. In the 8CH measure-
ments, the images of the individual coil channels were added
using the sum of squares method, after normalizing the indi-
vidual images to their noise level which was determined
within a region of interest (ROI) of air. For both measure-
ments exactly the same measurement parameters were used.
The SNR in pixel (x,y) of the ERC (SNRx;y;ERC) and 8CH
ðSNRx;y;8CH) measurements was determined by:
(a) (b) (c)
(d) (e) (f)
FIG. 1. 3D drawings of the endorectal coil without any balloon (a), with the inner balloon (b) and with the inner and outer balloon present (c). The 31P Tx/Rx
loop is positioned between the balloons while the 1H Rx elements is attached to the rod inside the inner balloon. The corresponding photos of the actual coil are
depicted in d, e, and f. A schematic cross section of the asymmetric 1H microstrip (g) shows its orientation and geometry. The copper colored (online version
only) parts indicate the conducting line and ground plane. [Color figure can be viewed at wileyonlinelibrary.com]
FIG. 2. Schematic of the electrical circuit of the 31P/1H combined endorectal coil. Orange/brown colored (online version only) parts indicate the copper used for
the actual 1H and 31P coils. [Color figure can be viewed at wileyonlinelibrary.com]
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SNRx;y;ERC 8CHð Þ ¼
Signalx;y
rERC 8CHð Þ
Here, rERC 8CHð Þ is an estimate for the noise within the pros-
tate. A region of air was used for this estimation to reduce the
influence of physiological noise and variation. rERC 8CHð Þ was
determined by correcting the standard deviation within the air
ROI for the Rayleigh distribution in single channel ERC
imaging and noncentral chi distribution in sum-of-squares
multichannel 8CH imaging.19,20
The ROI placement for noise calculation was the same for
both measurements. The ratio of the SNR of the ERC and the
external body array was determined by dividing the respec-
tive SNRs:
SNRratiox;y ¼ SNRx;y;ERCSNRx;y;8CH
The SNR ratio image was filtered by convoluting the
image with a 3 9 3 voxel wide block function.
2.C. Safety testing of the 31P/1H endorectal coil
Before performing any patient measurements, the setup
was thoroughly validated for safety. The SAR safety levels of
the setup were in part based on the simulations and measure-
ments of a previously validated design by Kobus et al.10 They
determined the safety levels of a 31P-only ERC in combina-
tion with the same external body array as used in this study.
Here we added a 1H Rx-only microstrip to their 31P ERC
design, which could influence the 31P loop coil performance.
Because of the close proximity of the ERC to tissue, this
could introduce safety concerns with respect to the maximum
allowed 31P transmit power. To demonstrate the safety of the
31P/1H ERC, we performed electromagnetic field simulations
of an experimental 31P/1H ERC design which we compared
with a design similar to that of Kobus et al.10 In addition, we
performed electromagnetic field measurements of this experi-
mental 31P/1H ERC to validate the simulation results. The
safety characteristics of the 31P/1H ERC were further investi-
gated by performing SAR simulations in a more realistic
prostate model and by performing in vivo temperature mea-
surements.
Additional phantom measurements using a network ana-
lyzer to assess coupling between the ERC and the external
coil array are presented in the Supporting Information S.1.
2.C.1. Electromagnetic field simulations and
phantom measurements
To promote reproducibility, the actual 31P loop coil was
replaced by a stiff printed circuit board (PCB) plate with the
same dimensions, in both simulations and measurements
(Fig. 3). The electromagnetic fields of 31P/1H ERC were ana-
lyzed by performing Finite Integration Technique (FIT) simu-
lations (CST Studio Suite 2011, Darmstadt, Germany) at
120.3 MHz of a three-dimensional (3D) model (Autodesk
Inventor, San Rafael, USA) of the 31P/1H endorectal coil and
a similar ERC without the 1H channel (31P-only ERC) resem-
bling the design by Kobus et al.10 In the simulations of the
3D models of the coils, the coils were surrounded by a phan-
tom fluid with a relative permittivity of r = 79 and a con-
ductivity of r = 0.47 S/m at a frequency of 120.3 MHz.
Additional measurements were performed of the 31P/1H ERC
using a setup with field probes (Schmid & Partner Engineer-
ing AG (SPEAG), Z€urich, Switzerland, probes H3DV7 &
ES3DV2) to collect E- and B-field measurements in the sagit-
tal plane in a phantom filled with liquid (r = 79, r = 0.49
S/m, measured with an Agilent 85070E dielectric probe kit at
120 MHz). To stay within the calibration range of the probes,
two different power settings were used: 0.01 W for the B-
field and 0.05 W for the E-field measurements. The measure-
ments were performed at 120 MHz in a 2D plane using a
sampling density of one sample per 5 9 5 mm2 area. A
sagittal plane of 150 9 30 mm2 was sampled in the midline
of the coil, 10–40 mm above the conductors.
2.C.2. SAR simulations
Electromagnetic field simulations (FIT) of the 31P loop
coil at 120.3 MHz in a more realistic prostate model were
performed to determine the SAR levels at 1 W transmit
power. The 31P/1H ERC was compared to the 31P-only ERC
in a model incorporating the different surrounding tissues
(Fig. 4). Both were simulated with the actual 31P loop coil
model (Fig. 1). The permittivity and electric conductivity val-
ues were obtained from literature.21
2.C.3. In vivo temperature measurements
In vivo temperature measurements were performed with
the complete setup: the 31P/1H ERC in combination with the
external 1H body array. Three thermocouples were attached
to the ERC at different locations (Fig. 5). One temperature
sensor was placed at the feed point of the coil, the location
of the hotspot in previous SAR simulation by Kobus et al,10
and the other two sensors were attached to the cable to
ensure no safety compromising common modes were pre-
sent. The thermocouple at the feeding point was attached to
the outer side of the external balloon and a thin condom was
used to cover the ERC and thermocouples. The insulating
effect of this thin latex layer was expected to be of minimal
influence and was therefore neglected. Two different safety
tests were performed. The ERC was applied as usual and for
the first test a time-averaged input power of 1.9 W10 was
used for a duration of 6 min on the 31P channel. For the sec-
ond test the external 1H body array was used with a power
of 40 W for 2:30 min to test for any coupling between the
body array and the ERC.
2.D. Patient measurements
To demonstrate the feasibility of the complete setup, all
patient measurements were performed with the external
body array coil for 1H transmit only and the 31P/1H ERC for
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1H receive and 31P transmit and receive (see Figure S-2 in
Supporting Information S.3 in for a schematic overview of
the in vivo setup). After a localizer and B0 shimming, B1
+
shimming was performed by using the B1TIAMO technique
22 to acquire absolute B1
+ maps and by maximizing the
phase coherence of the individual coil channels in an ROI
within the prostate. 1H T2-weighted imaging and diffusion-
weighted imaging were then performed with an in-plane
spatial resolution of respectively 0.43 9 0.43 mm2 and
1.75 9 1.75 mm2.
Proton MRSI was performed using a PRESS-like
sequence with RF refocusing pulses that are both spectrally
and spatially selective, such that the signal of a volume of
interest (VOI) is received only from the spectral region of
interest (2.3–3.3 ppm).23 31P MRSI was performed using a
3D phase-encoded pulse-acquire sequence with a
(a) (b) (c) (d)
(e) (f) (g) (h)
FIG. 3. Electromagnetic field simulations of the 31P loop coil in transmit mode of the 31P-only (E-field: a, B-field: e) and the 31P/1H (E-field: b, B-field: f) ERC.
The corresponding experimental measurements of the 31P/1H ERC (E-field: c, B-field: g) are shown as well. An overview image (d) and a picture of the modified
PCB coil (h) show the measurement setup and the sagittal plane (blue (online version only) plane) that was used to perform the measurements. The 3D model
used for the simulations is shown in (i). X indicates the distance from the conductors in mm. Both the simulations and measurements were performed within the
same plane. The feed of the coil was positioned at the bottom of the E- and B-field maps, and the top of the coil was positioned at the top of the maps. For the
actual measurements, the transparent box (d) containing the coil was filled with tissue simulating fluid and the loop was covered with a balloon. ERC, endorectal
radiofrequency coil. [Color figure can be viewed at wileyonlinelibrary.com]
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nonselective BIR-4 excitation pulse9 (see Table I for further
imaging and spectroscopy details). The nuclear Overhauser
effect was used with continuous low-power irradiation of the
water resonance to enhance 31P SNR.15 31P MRSI data was
fitted using Metabolite Report (Siemens Healthineers Erlan-
gen, Germany). PE, PC, GPE, and GPC were modeled as a
triplet of three Gaussian peaks with a separation equal to the
J-coupling (6–7.1 Hz) and amplitudes in a 1:2:1 ratio. The
PCr lineshape, which was fitted with a single Gaussian shape,
was used as a constraint to the linewidth for all signals.9 The
spectra shown in this work were corrected for constant and
linear phase, an exponential time filter (40 ms for 31P and
150 ms for 1H) was applied and the spectra were zero-filled
to 2048 points. In the 31P spectra the PCr signal was refer-
enced to 0.0 ppm and in the 1H spectra water was referenced
to 4.7 ppm.
3. RESULTS
The 31P/1H ERC was constructed according to the circuit
and model specifications (Figs. 1 and 2) and all validations
and in vivo experiments were performed successfully.
(a) (b) (c)
FIG. 4. SAR simulations of the 31P transceiver loop coil in transmit mode of the 31P-only ERC (a) and the 31P/1H ERC (b). The ERC model with the actual 31P
loop coil (Fig. 1) was used for the simulations. The simulations were performed with a model (c) to get a realistic simulation environment (prostate: r = 72.8,
r = 0.923 S/m, q = 1045 kg/m3; bladder: r = 22, r = 0.297 S/m, q = 1035 kg/m
3; lipids: r = 12.4, r = 0.0694 S/m, q = 911 kg/m
3; rectum: r = 64,
r = 0.717 S/m, q = 1045 kg/m3, muscle: r = 64, r = 0.717 S/m, q = 1090 kg/m
3). ERC, endorectal radiofrequency coil. [Color figure can be viewed at wile
yonlinelibrary.com]
FIG. 5. In vivo transversal (a) and sagittal (b) image of the prostate of a volunteer, illustrating the standard endorectal coil position during prostate MR examina-
tions. The position of the temperature sensors that were placed during the in vivo temperature measurements are depicted on the sagittal image (b). The tempera-
ture during the 31P (at 1.9 W, left graph) and 1H (at 40 W, right graph) transmit period is depicted for sensor 1, 2, and 3 (c). The dashed lines indicate the period
in which power was transmitted (6 min for 31P and 2.5 min for 1H). MR, magnetic resonance. [Color figure can be viewed at wileyonlinelibrary.com]
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Simulations of the B1
 profile of the 1H microstrip were
performed and are shown in the Figure S-1 in Supporting
Information S.2.
3.A. Safety
The electromagnetic field simulations to test the safety
when transmitting at 31P showed no differences between the
31P-only ERC by Kobus et al.10 and the 31P/1H ERC proposed
in this work (Fig. 3). The hotspot with respect to the electric
field in both the 31P-only and the 31P/1H ERC was identified
at the same location at the feed point of the coil. Both the E-
and B-field simulations corresponded well with the actual
measurements of the 31P/1H ERC, yielding similar E- and B-
field peak locations and intensities. The SAR simulations in
the prostate tissue model also showed no substantial differ-
ences between the two coils. Maximum SAR10g values of
9.48 W/kg for the 31P-only ERC and 9.42 W/kg for the
31P/1H ERC were found at the feed point of the coil when
transmitting with the 31P loop coil at 1 W (Fig. 4).
When transmitting on 31P at 1.9 W power, the in vivo tem-
perature measurements showed a maximum temperature
increase of approximately 0.7°C over 6 min at the feed point of
the coil, converging to a plateau in the second half of the 6-min
period. The maximum temperature increase measured at the
sensors located on the cable was < 0.5°C. When transmitting
with the external 1H body array at 40 W for 2:30 min, the tem-
perature increase was less than 0.3°C in any of the temperature
sensors, indicating that there is no significant coupling between
the external array and the ERC (Fig. 5).
There was no evidence for any significant coupling
between the 1H ERC channel, the 31P ERC channel and the
external body array in the phantom measurements with the
network analyzer. There was also no influence when manipu-
lating the cables (Table S-1 in Supporting Information S.1).
3.B. Volunteer and patient measurements
Using the external body array for 1H transmit resulted in a
homogeneous flip angle distribution over an ROI in the prostate
of the volunteer of 78.5  3.9° (Figure S-2 in Supporting
Information S.3). In combination with the high local sensitivity
of the ERC’s 1H Rx channel, this allowed high resolution T2W
and DW imaging without artifacts (Fig. 7, Figure S-3 in Sup-
porting Information S.4). The ERC’s 1H asymmetric microstrip
showed improved SNR in the prostate of the healthy volunteer
when compared with the external array, up to 3.5 cm anterior
to the ERC at the center of the microstrip and 3 cm when
20 mm superior or inferior to the center of the microstrip
[(Fig. 6(d) and 6(f)]. In the midline through the ERC, 1 cm into
the prostate, the SNR (mean  standard error of the mean)
over the center ten voxels was 316  7 for the ERC microstrip
and 59  0.6 for the 8CH array. Due to the asymmetric micro-
strip design, the receive profile is symmetric with respect to
and oriented toward the prostate [Fig. 6(c)], (Figure S-1 in Sup-
porting Information S.2). Thirty millimeters anterior to the
ERC, the ERC had a higher SNR than the 8CH within a range
of ≥ 30 mm in the left-right direction [Fig. 6c and 6(e)].
We were able to detect prostate cancer lesions in the three
patients with the imaging sequences, such that voxels with
TABLE I. Sequence parameters
T2W DWI
31P MRSIb 1H MRSI
Sequence type Turbo-Spin-Echo EPI (RESOLVE); b0, b100,
b400, and b800
3D MRSI with non-selective
BIR-4 excitation
PRESS-like with spectrally and spatially
selective RF refocusing pulses
FOV 111 9 111 mm2 154 9 154 mm2 a): 120 9 100 9 100 mm3
b): 120 9 120 9 120 mm3
84 9 70 9 70 mm3
Matrix 256 9 256 88 9 88 a): 12 9 10 9 10
b): 10 9 10 9 10
12 9 10 9 10
Voxel sizea 0.43 9 0.43 9 3 mm3 1.75 9 1.75 9 3 mm3 a): 4.9 cc
b): 9.1 cc
1.4 cc
Slices 19 19 n.a. n.a.
Slice thickness 3 3 n.a. n.a.
TR (ms) 4250 4400 1500 1000
TE (ms) 84 68 n.a. 135
Bandwidth (Hz) 106 (per pixel) 1015 10000 (spectral) 2400 (spectral)
Vector size n.a. n.a. 2048 1024
Averages 1 1 4 (weighted) 1
Acquisition time
(min:sec)
1:59 4:34 13:09 7:01
Flip angle (⁰) n.a. n.a. 45 n.a.
Filter Prescan normalization
filter
n.a. 100% Hamming filter 50% Hamming filter
DWI, diffusion-weighted imaging; MRSI, magnetic resonance spectroscopic imaging.
aFor the MRSI measurements, this was based on the true voxel size based on voxel volume within the 50% range of the maximum of the point spread function after correct-
ing for spatial filter and sampling scheme.
bTwo different measurement parameter sets were used: set a) and set b).
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FIG. 6. Gradient echo imaging of the prostate of a healthy volunteer in transversal (a) and sagittal (b) orientation using the 8-channel external body array (8CH).
The red circles (online version only) indicate the outline of the prostate and the black circle (online version only) indicates the outline of the seminal vesicles.
The dashed lines indicate the location of the transversal and sagittal slice with respect to each other (a, b), the white box indicates the position of the respective
colormap image (c, d) and the red box indicates the ROI in air that was used to estimate the noise. A map of the ratio of the SNR (SNRERC/SNR8CH) obtained
with only the ERC’s 1H asymmetric microstrip and only the 8CH array was determined and overlaid on the GRE transversal (c) and sagittal (d) imaging. The
cross section of the SNR ratio was obtained at three different locations in the left right direction on the transversal imaging at 10, 20, and 30 mm anterior to the
endorectal coil (e). The cross section of the SNR ratio was also determined at three different locations on the sagittal images, through the center of the ERC and
20 mm superior and inferior to center of the ERC (f). The natural logarithm of the SNR ratio (ln(SNRERC/SNR8CH)) was plotted with respect to the location. The
first pixel anterior to the ERC with actual signal was taken as x = 0 for the sagittal cross section and the center of the prostate was used as x = 0 in the transversal
cross section. The absolute SNR of the ERC and the 8CH are also shown for the cross section at 10 mm anterior to the ERC on the transversal image (g) and for
the central cross section on the sagittal image (h). ERC, endorectal radiofrequency coil; ROI, region of interest; SNR, signal-to-noise. [Color figure can be viewed
at wileyonlinelibrary.com]
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1H and 31P spectra could be localized within these lesions.
Prostate cancer lesions were verified by MR-guided biopsy
(one patient), MR-TRUS guided biopsy (one patient) or
TRUS biopsy and 3T clinical MRI results (one patient). The
ERC’s sensitivity profile was wide enough to perform T2W
and DW imaging of the seminal vesicles, apex of the prostate,
and anterior regions of the prostate (Fig. 7), even in a rela-
tively large prostate (Figure S-3 in Supporting Information
S.4). Due to the overlap between the 31P and 1H sensitivity
profiles, 31P spectroscopy of those regions can be obtained as
well with sufficient SNR to measure PE and PC in a healthy
volunteer or patient (Fig. 7, Fig. 8). The 1H spectral map
shows adequate SNR for citrate and spermine from apex to
base in the prostate. The line widths achieved after B0 shim-
ming within a VOI around the prostate ranged from 30–
60 Hz. Close to the ERC and in the seminal vesicles the spec-
tral map shows wider peaks because those areas are generally
harder to B0 shim properly. This was less noticeable in the
31P spectra due to the larger ppm difference of the 31P signals.
For both 31P and 1H spectroscopy the signal drops anteriorly
in prostate.
31P spectroscopic imaging was obtained successfully in
the volunteer and in all patients. PE, PC, PCr, and c- and
aNTP were detectable in spectra that were located within the
prostate. Similar to previous results9 the PDEs were occa-
sionally within detectable ranges, and if so, they were well
separable (Fig. 8). 1H spectroscopy showed well distinguish-
able tCho and Spm signals and also showed Cit which occa-
sionally suffered from lipid contamination. High spermine
signals were present in 1H spectra (Fig. 8, Figure S-3 in Sup-
porting Information S.4).
In one of the patients with a high-grade Gleason 4 + 4
prostate cancer lesion the GPC, GPE, and PC levels were
clearly identifiable and elevated in the spectra located within
the cancer lesion, whereas these signals were almost absent
in contralateral healthy prostate tissue (Fig. 8). PCr, which is
mostly present in muscle tissue, could serve as an indicator
for the 31P coil sensitivity profile due to its assumed
FIG. 7. T2W imaging, DWI ADC maps,
31P MRSI spectral maps (31P), and 1H MRSI spectral maps (1H) of three different regions of a healthy volunteer (40 yr,
83 kg): the apex, mid-prostate, and the seminal vesicles (SV). The spectral maps of 31P MRSI were taken of the spectral region 4.6–8.3 ppm, showing the PE sig-
nal (left peak) and PC signal (right peak). In some spectra, the inorganic phosphate (Pi) signal is also visible on the right of the spectrum. The 1H spectra are
shown of the spectral region 2.3–3.6 ppm, showing mainly spermine (left side of the spectrum) and citrate (right side of the spectrum). 31P MRSI measurement
set a) was used. To provide a more detailed view, four of these spectra are shown separately (Spectra), two for 31P (green and red), and two for 1H (yellow and
blue). The location of these spectra is indicated with colored boxes (online version only) on the spectral maps. DWI, diffusion-weighted imaging; MRSI, mag-
netic resonance spectroscopic imaging. [Color figure can be viewed at wileyonlinelibrary.com]
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symmetric distribution over the prostate and nearby smooth
muscles. As PCr was highest on the healthy side of the pros-
tate, the GPE, GPC, and PC elevations in the lesion were not
caused by any asymmetry in the coil profile, but were due to
real locally increased metabolite levels. The increase in 31P
metabolites in tumor tissue corresponded with an elevated 1H
tCho peak, which was absent on the contralateral side of the
prostate. Other patients did not show detectable GPC or GPE
within the cancer lesion (Figure S-4 in Supporting Informa-
tion S.4).






FIG. 8. GPC + GPE, PC + PE, and PCr metabolite maps of a patient with metastatic Gleason 4 + 4 prostate cancer (67 yr old, 88 kg, MR-TRUS guided
biopsy) (a,b, and c) overlaid over a T2-weighted image. The corresponding ADC map (d) is also shown, indicating a large prostate cancer lesion on the right side
of the prostate. 1H (e,f) and 31P (g,h) spectra are shown of the cancer lesion (red circle) as well as a location within healthy tissue (blue circle) (online version
only). 31P MRSI measurement set a) was used. GPC, glycerophosphocholine; GPE, glycerophosphoethanolamine; MRSI, magnetic resonance spectroscopic
imaging; PC, phosphocholine; PE, phosphoethanolamine.
Medical Physics, 46 (9), September 2019
3902 Philips et al.: 31P and 1H prostate MR at 7 Tesla 3902
4. DISCUSSION
31P spectroscopic imaging of the prostate is only possible
with an ERC at an ultra-high field strength. When adding a 1H
receive channel to the ERC and combining it with an external
body array coil for 1H transmit, 31P spectroscopic imaging can
be performed within the same MR examination as high-resolu-
tion prostate imaging and 1H spectroscopic imaging.
4.A. Safety
To validate the safety of our setup, we used the results of
previous work by Kobus et al10 with a 31P Tx/Rx ERC com-
bined with an external body coil. Their work showed no sub-
stantial coupling between the ERC and the external body array.
Furthermore, when transmitting at 31P with a power of 1.9 W
their simulations stayed within the SAR10g limit of the first level
operation mode in the hotspot at the feed of the coil.
In our proposed 31P Tx/Rx – 1H Rx endorectal coil, we
added a 1H receive microstrip to the 31P Tx/Rx ERC by
Kobus et al.10 This addition may pose safety concerns for the
31P transmit safety levels. We performed electromagnetic
field and SAR simulations of both the 31P-only ERC by
Kobus et al and our proposed design with an additional 1H
microstrip and found no influence of the 1H microstrip on the
simulation results or local hotspot locations. We also vali-
dated these results with experimental phantom measure-
ments. These results indicate that we can use the SAR safety
levels of Kobus et al10 for our design and that our design stays
within the local SAR10g limit of first level operation mode
when transmitting at 1.9 W on 31P. Moreover, new in vivo
temperature measurements of the proposed 31P/1H ERC also
showed a temperature increase < 1°C in the local hotspot
when transmitting at this power level, again indicating safe
power levels.
4.B. In vivomeasurements
Kobus et al10 and Lagemaat et al9 used a measurement
setup with an external body array in combination with a 31P-
only ERC, which allowed them to obtain imaging and 31P
spectroscopy. No 1H spectroscopic imaging was performed,
as this is challenging without a local receive coil due to SNR
restrictions. In this work we equipped the ERC with a 1H Rx
element to substantially increase local receive sensitivity. Not
only did this facilitate the acquisition of 1H MRSI, it also
enabled high resolution T2W imaging and DWI with a
zoomed field-of-view of the prostate. The imaging resolution
was substantially higher than the reported spatial resolution
of 0.75 9 0.75 9 3 mm3 in earlier work at 7T without an
ERC24 and similar to the resolution of 0.4 9 0.4 9 3 mm3
in earlier work at 3Twith a dedicated 1H ERC.25 This resolu-
tion is possible due to the SNR increase that the ERC 1H
microstrip offered in the prostate. Up to 3.5 cm anterior to
the ERC, the ERC has a higher SNR than the 8-channel exter-
nal body array, which is comparable to previously published
work on 1H imaging at 7T.26 When combined with the exter-
nal body array for receive, the ERC would provide additional
performance up to about 5 cm in the prostate (when taking
the  0.5 logarithmic SNR ratio criterium for added benefit
in Fig. 6). The SNR measurements were performed in one
healthy volunteer of average body composition and we cor-
rected for differences in noise distribution between the recon-
struction algorithms used, to perform a fair comparison. The
SNR gain of the ERC with respect to a multichannel array
surely also depends upon the exact body composition: in lar-
ger body circumferences the elements of the external coil
array are further away from the prostate, decreasing their
SNR within the prostate, increasing the relative SNR contri-
bution from the ERC over a larger area. The opposite holds
for smaller body compositions. The overlap in the 31P and 1H
sensitivity profile of the ERC allowed combining 1H with 31P
MRSI in the same patient, enabling us to correlate tCho sig-
nals to individual phosphorus containing choline signals.
Because of the SNR constraints of spectroscopy, the ERC
might not be optimal for assessing the anterior regions of
(very) large prostates, as the sensitivity profile of an ERC
drops significantly at large distances.
Because of the increased SNR due to the use of 7T MRI
in combination with the nuclear Overhauser effect, 31P spec-
troscopic imaging was obtained with high quality spectra in
all patients, using a spectroscopic imaging method to accu-
rately localize signals. Although the true voxel size was 4.9 or
9.1 cc, it allows voxel localization with respect to the T2W
and DWI images within or covering suspicious lesions,
instead of relying on coil profile-based localization with an
unlocalized pulse sequence. Using a 31P/1H ERC without
external multitransmit array coil also enables the acquisition
of 31P and 1H MRSI. However, one would need to revert to
the use of many adiabatic RF refocusing pulses and T2-
weighted MRI and DWI becomes particularly problematic
with the use of only a small endorectal coil 12.
1H MRSI was also obtained with a high SNR and with
well distinguishable tCho and Spm signals, but it suffered
from lipid contamination in some cases. This is most likely
caused by B0 inhomogeneities, the small chemical shift sepa-
ration between the citrate and lipid signals and the spectral
selectivity of the spectral-spatial pulses of the 1H spec-
troscopy sequence. 1H MRSI was performed with a corrected
voxel size of 1.4 cc, enabling voxel localization within or
covering lesions. The spectral spatial refocusing pulses selec-
tively inverted the 3.1 ppm resonance of Spm, refocusing its
J-coupling at the echo time,23 resulting in high spermine sig-
nals that might yield additional biological information.1,27
In the seminal vesicles, an increased PC/PE ratio and a
high tCho signal with an almost absent Spm peak were found
(Figure S-3 in Supporting Information S.4). In one particular
case (Fig. 8) with an aggressive Gleason 4 + 4 prostate can-
cer with bone metastases, increased levels of total choline
were observed in the cancer lesion. The elevated tCho corre-
lated with increases in GPE, GPC, and PC levels and sug-
gests an increased degradation of membrane phospholipids.7
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Although there is a correlation between 31P and 1H choline
signals, it appears as though the increase in 31P metabolites
cannot completely account for the large difference in tCho
levels observed between cancer and normal tissue. This indi-
cates that also other overlapping signals, such as free choline,
change significantly, but drawing conclusions about specific
free choline levels may be difficult using the current setup.
Due to the ERC profile, absolute quantification of the
metabolites is difficult and necessitates the use of metabolite
ratios or coil profile corrections to draw more quantitative
conclusions. For 31P spectroscopy, relevant ratios would be
PDE/PME, PC/PE, or PE/(PDE + PME).9 For 1H spec-
troscopy tCho/Spm could be used, as tCho tends to be ele-
vated in cancer lesions, whereas spermine tends to decrease
in cancer tissue.27
5. CONCLUSION
Using a 31P Tx/Rx 1H Rx endorectal coil in combination
with an external multitransmit 1H body array enables high
resolution multiparametric MR imaging and 1H and 31P spec-
troscopy of the prostate at 7T. The setup does not pose any
safety issues and provides superior 1H SNR locally in the
prostate in comparison with a 1H external body array alone.
The clinical data shown in this study are anecdotal but they
illustrate how the proposed setup would be particularly suit-
able to combine anatomically and functionally with metabolic
imaging in prostate cancer.
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SUPPORTING INFORMATION
Additional supporting information may be found online in
the Supporting Information section at the end of the article.
Figure S-1: B1
 simulations of the 1H Rx asymmetric
microstrip (a,c,e) and a loop coil with similar length (b,d,f).
Figure S-2: A schematic transversal overview of the
complete in vivo measurement setup, including a transversal
flip angle map through the abdomen (volunteer, age
40 years, weight 83 kg) when transmitting with the
combined 8-channel coil array after B1
+ shimming.
Figure S-3: Transversal T2W imaging of a patient (60 years
old, 97 kg) in the seminal vesicles (a), the mid-prostate (b)
and the apex (c) of the prostate.
Figure S-4: ADC map (a), T2W image (b) and
31P MRSI
spectrum (c) of a patient (63 years, 83 kg) with prostate
cancer (Gleason 3+4).
Table S-1: Coupling between 31P/1H endorectal coil and
external 1H body array in dB.
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